The Patent Finder

Ethris GmbH

21 patents currently held · Updated Nov 22, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Dec 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Conjugate with Target-Finding Ligand and Use Thereof (US 10,583,195) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Minimal UTR sequences (US 11,981,910) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 24, 2026
  • 2 terms have ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,555,122Conjugate with Target-Finding Ligand and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,583,195Conjugate with Target-Finding Ligand and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 10,745,698RNA with a combination of unmodified and modified nucleotides for protein expression
In force
 · USPTO record
In forceUSPTO record
US 11,090,264Pulmonary Delivery of Mrna to Non-Lung Target Cells
In force
 · High confidence
In forceHigh confidence
US 12,064,484Compositions for introducing RNA into cells
In force
 · USPTO record
In forceUSPTO record
US 10,272,161RNA for Use in the Treatment of Ligament or Tendon Lesions
In force
 · High confidence
In forceHigh confidence
US 11,065,346RNA for use in the treatment of ligament or tendon lesions
In force
 · USPTO record
In forceUSPTO record
US 12,263,229Induction of osteogenesis by delivering BMP encoding RNA
In force
 · USPTO record
In forceUSPTO record
US 12,594,295CFTR Mrna Compositions and Related Methods and Uses
In force
 · Medium confidence
In forceMedium confidence
US 11,479,768ATP-binding cassette family coding polyribonucleotides and formulations thereof
In force
 · USPTO record
In forceUSPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 5 patents in force now held by others · 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 1 abandoned · 9 no status recorded

Showing 1 to 10 of 14, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/248,327Use of Ifn-Lambda Mrna for Treating Viral InfectionsJun 24, 2025Pending
18/798,342Compositions for Introducing RNA into CellsAug 8, 2024Pending
18/277,965Formulations for Aerosol Formation and Aerosols for the Delivery of Nucleic AcidFeb 25, 2022Pending
18/035,249Use of Ifn-Lambda Mrna for Treating Viral InfectionsNov 4, 2021Pending
16/924,158Jul 8, 2020No status recorded
17/268,435Lipid-Based Formulations Containing Salts for the Delivery of RNAAug 12, 2019Abandoned
17/050,441Apr 25, 2019No status recorded
14/697,470Apr 27, 2015No status recorded
14/628,014Feb 20, 2015No status recorded
14/628,008Feb 20, 2015No status recorded
10 of 14 applications shown.
Pro members see all 14 published applications.
Pro members: see all 14 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited